| Autophagy proteins regulate the secretory component of osteoclastic bone resorption CJ DeSelm, BC Miller, W Zou, WL Beatty, E van Meel, Y Takahata, ... Developmental cell 21 (5), 966-974, 2011 | 506 | 2011 |
| Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer S Hegde, VE Krisnawan, BH Herzog, C Zuo, MA Breden, BL Knolhoff, ... Cancer cell 37 (3), 289-307. e9, 2020 | 317 | 2020 |
| Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape C DeSelm, ML Palomba, J Yahalom, M Hamieh, J Eyquem, ... Molecular Therapy 26 (11), 2542-2552, 2018 | 194 | 2018 |
| Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes PB Romesser, O Cahlon, ED Scher, EB Hug, K Sine, C DeSelm, JL Fox, ... International Journal of Radiation Oncology* Biology* Physics 95 (1), 386-395, 2016 | 172 | 2016 |
| IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner CJ DeSelm, Y Takahata, J Warren, JC Chappel, T Khan, X Li, C Liu, ... Journal of cellular biochemistry 113 (9), 2895-2902, 2012 | 133 | 2012 |
| CARD8 is an inflammasome sensor for HIV-1 protease activity Q Wang, H Gao, KM Clark, CS Mugisha, K Davis, JP Tang, GH Harlan, ... Science 371 (6535), eabe1707, 2021 | 109 | 2021 |
| AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake R Rashmi, C DeSelm, C Helms, A Bowcock, BE Rogers, J Rader, ... PloS one 9 (4), e92948, 2014 | 94 | 2014 |
| CAR T‐cell therapy for pancreatic cancer CJ DeSelm, ZE Tano, AM Varghese, PS Adusumilli Journal of surgical oncology 116 (1), 63-74, 2017 | 89 | 2017 |
| Early experience using salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy BS Imber, M Sadelain, C DeSelm, C Batlevi, RJ Brentjens, PB Dahi, ... British journal of haematology 190 (1), 45-51, 2020 | 55 | 2020 |
| Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma J Setton, J Han, D Kannarunimit, YR Wuu, SA Rosenberg, C DeSelm, ... Oral oncology 53, 67-73, 2016 | 49 | 2016 |
| A 3-dimensional mapping analysis of regional nodal recurrences in breast cancer C DeSelm, TJ Yang, O Cahlon, J Tisnado, A Khan, E Gillespie, S Powell, ... International Journal of Radiation Oncology* Biology* Physics 103 (3), 583-591, 2019 | 40 | 2019 |
| Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy K Kramer, N Pandit-Taskar, P Zanzonico, SL Wolden, JL Humm, ... Journal of Neuro-oncology 123, 245-249, 2015 | 29 | 2015 |
| Halofuginone prevents estrogen‐deficient osteoporosis in mice CJ DeSelm, W Zou, SL Teitelbaum Journal of cellular biochemistry 113 (10), 3086-3092, 2012 | 25 | 2012 |
| MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy B Imber, ML Palomba, C DeSelm, CL Batlevi, PB Dahi, SA Giralt, A Noy, ... Blood 134, 3238, 2019 | 22 | 2019 |
| Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells HJ Kim, JT Warren, SY Kim, JC Chappel, CJ DeSelm, FP Ross, W Zou, ... Journal of cellular biochemistry 111 (5), 1107-1113, 2010 | 21 | 2010 |
| Paxillin contracts the osteoclast cytoskeleton W Zou, CJ DeSelm, TJ Broekelmann, RP Mecham, S Vande Pol, K Choi, ... Journal of Bone and Mineral Research 27 (12), 2490-2500, 2012 | 18 | 2012 |
| Potential abscopal response to dual checkpoint blockade in RCC after reirradiation using dose-painting SBRT Q LaPlant, C Deselm, NA Lockney, J Hsieh, Y Yamada Practical Radiation Oncology 7 (6), 396-399, 2017 | 16 | 2017 |
| The current and future role of radiation therapy in the era of CAR T-cell salvage C DeSelm The British Journal of Radiology 94 (1127), 20210098, 2021 | 12 | 2021 |
| Overall survival of breast cancer patients with locoregional failures involving internal mammary nodes AJ Xu, CJ DeSelm, AY Ho, EF Gillespie, LZ Braunstein, AJ Khan, ... Advances in Radiation Oncology 4 (3), 447-452, 2019 | 9 | 2019 |
| Rho-kinase is required for myosin-II-mediated vesicle transport during M-phase in extracts of clam oocytes T Wollert, AS DePina, CJ DeSelm, GM Langford The Biological Bulletin 205 (2), 195-197, 2003 | 8 | 2003 |
